Esthesioneuroblastoma : the complete picture - case report and review of the literature
Esthesioneuroblastoma (ENB), also called olfactory neuroblastoma, is a cancerous tumor originating from the olfactory neuroepithelial cells frequently invading the brain through the cribriform plate. The optimal therapy is the multimodality treatment involving a group of physicians trained in different medical specialties. Establishing a careful histopathological diagnostic and treatment planning based on a multidisciplinary approach is of paramount importance. The treatment of ENB correlates with the extent of the lesion, with surgery being the mainstay of therapy followed by postoperative irradiation. Surgery, when complete, image-verified and associated with radiation therapy results in long-term survival and presents a very low probability of illness recurrence. We present the case of a 46-year-old female with ENB, who was operated on in the Clinic of Neurosurgery of the National Institute of Neurology and Neurovascular Diseases in Bucharest, Romania, through a bifrontal craniotomy approach. Gross total resection of the intracranial extent was performed. The pathological diagnosis revealed an aggressive olfactory neuroblastoma. Three weeks after discharge from hospital, the tumor was completely resected through a lateral rhinotomy performed by an otorhinolaryngologist. Six weeks later, the patient received adjuvant therapy (radiotherapy and chemotherapy). The outcome was favorable, with no tumor recurrence at 20 months postoperatively. Our case demonstrates that even when dealing with a visibly aggressive tumor, a correct diagnosis, accurate classification and grading along with appropriate therapy ensure a favorable outcome.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
---|---|
Enthalten in: |
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie - 59(2018), 4 vom: 08., Seite 1211-1218 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Toader, Corneliu [VerfasserIn] |
---|
Themen: |
68238-35-7 |
---|
Anmerkungen: |
Date Completed 08.04.2019 Date Revised 08.04.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM294691502 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM294691502 | ||
003 | DE-627 | ||
005 | 20231225082033.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0982.xml |
035 | |a (DE-627)NLM294691502 | ||
035 | |a (NLM)30845303 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Toader, Corneliu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Esthesioneuroblastoma |b the complete picture - case report and review of the literature |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.04.2019 | ||
500 | |a Date Revised 08.04.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Esthesioneuroblastoma (ENB), also called olfactory neuroblastoma, is a cancerous tumor originating from the olfactory neuroepithelial cells frequently invading the brain through the cribriform plate. The optimal therapy is the multimodality treatment involving a group of physicians trained in different medical specialties. Establishing a careful histopathological diagnostic and treatment planning based on a multidisciplinary approach is of paramount importance. The treatment of ENB correlates with the extent of the lesion, with surgery being the mainstay of therapy followed by postoperative irradiation. Surgery, when complete, image-verified and associated with radiation therapy results in long-term survival and presents a very low probability of illness recurrence. We present the case of a 46-year-old female with ENB, who was operated on in the Clinic of Neurosurgery of the National Institute of Neurology and Neurovascular Diseases in Bucharest, Romania, through a bifrontal craniotomy approach. Gross total resection of the intracranial extent was performed. The pathological diagnosis revealed an aggressive olfactory neuroblastoma. Three weeks after discharge from hospital, the tumor was completely resected through a lateral rhinotomy performed by an otorhinolaryngologist. Six weeks later, the patient received adjuvant therapy (radiotherapy and chemotherapy). The outcome was favorable, with no tumor recurrence at 20 months postoperatively. Our case demonstrates that even when dealing with a visibly aggressive tumor, a correct diagnosis, accurate classification and grading along with appropriate therapy ensure a favorable outcome | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Ki-67 Antigen |2 NLM | |
650 | 7 | |a S100 Proteins |2 NLM | |
650 | 7 | |a Keratins |2 NLM | |
650 | 7 | |a 68238-35-7 |2 NLM | |
700 | 1 | |a Stroi, Marian |e verfasserin |4 aut | |
700 | 1 | |a Kozma, Andrei |e verfasserin |4 aut | |
700 | 1 | |a Arsene, Dorel Eugen |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie |d 1996 |g 59(2018), 4 vom: 08., Seite 1211-1218 |w (DE-627)NLM012659045 |x 2066-8279 |7 nnns |
773 | 1 | 8 | |g volume:59 |g year:2018 |g number:4 |g day:08 |g pages:1211-1218 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 59 |j 2018 |e 4 |b 08 |h 1211-1218 |